Clinical Trial Update: Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating LOSEC for decreasing iron absorption in patients with Congenital dyserythropoietic anemia Type I; the study status is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Dyserythropoietic Anemia Type

Drugs mentioned

• LOSEC

Snippet

Sponsor: Soroka University Medical Center | Conditions: CDA Type I | Phase 4 | Status: UNKNOWN